Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 15 | 2019 | 461 | 2.660 |
Why?
|
| Breast Neoplasms | 31 | 2023 | 2887 | 2.410 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 10 | 2019 | 466 | 1.470 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2023 | 3352 | 0.950 |
Why?
|
| Radiographic Image Enhancement | 6 | 2019 | 462 | 0.710 |
Why?
|
| ROC Curve | 15 | 2023 | 752 | 0.690 |
Why?
|
| Risk Assessment | 6 | 2019 | 2261 | 0.640 |
Why?
|
| Algorithms | 13 | 2023 | 1830 | 0.640 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2019 | 663 | 0.550 |
Why?
|
| Genomics | 2 | 2019 | 720 | 0.500 |
Why?
|
| Image Enhancement | 8 | 2018 | 563 | 0.480 |
Why?
|
| Diagnosis, Computer-Assisted | 5 | 2013 | 332 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1313 | 0.460 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 184 | 0.440 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 1204 | 0.410 |
Why?
|
| Pattern Recognition, Automated | 7 | 2013 | 217 | 0.410 |
Why?
|
| Breast | 6 | 2018 | 286 | 0.350 |
Why?
|
| Female | 32 | 2023 | 44507 | 0.320 |
Why?
|
| Artificial Intelligence | 4 | 2023 | 298 | 0.310 |
Why?
|
| Genes, BRCA2 | 3 | 2014 | 160 | 0.290 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8475 | 0.280 |
Why?
|
| Middle Aged | 16 | 2023 | 25017 | 0.250 |
Why?
|
| Genes, BRCA1 | 3 | 2014 | 192 | 0.240 |
Why?
|
| Breast Density | 3 | 2019 | 31 | 0.240 |
Why?
|
| Adult | 15 | 2019 | 25640 | 0.240 |
Why?
|
| Phenotype | 5 | 2019 | 2377 | 0.240 |
Why?
|
| Machine Learning | 3 | 2023 | 232 | 0.230 |
Why?
|
| Aged | 13 | 2019 | 18402 | 0.220 |
Why?
|
| Humans | 33 | 2023 | 86601 | 0.220 |
Why?
|
| Software | 5 | 2023 | 654 | 0.220 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 6501 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 2270 | 0.200 |
Why?
|
| Tumor Burden | 2 | 2019 | 288 | 0.190 |
Why?
|
| BRCA2 Protein | 3 | 2008 | 158 | 0.190 |
Why?
|
| Contrast Media | 7 | 2019 | 1077 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2014 | 812 | 0.180 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mutation | 5 | 2015 | 3967 | 0.160 |
Why?
|
| Area Under Curve | 4 | 2013 | 334 | 0.150 |
Why?
|
| Bayes Theorem | 3 | 2013 | 361 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2014 | 839 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 294 | 0.140 |
Why?
|
| BRCA1 Protein | 2 | 2008 | 200 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 80 | 0.130 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 22 | 0.130 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 156 | 0.120 |
Why?
|
| Diagnostic Imaging | 3 | 2021 | 469 | 0.120 |
Why?
|
| Fourier Analysis | 1 | 2014 | 125 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1384 | 0.120 |
Why?
|
| Multigene Family | 1 | 2014 | 202 | 0.110 |
Why?
|
| Subtraction Technique | 2 | 2011 | 133 | 0.110 |
Why?
|
| Age Factors | 2 | 2008 | 1849 | 0.110 |
Why?
|
| Risk Management | 1 | 2012 | 43 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 274 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2012 | 229 | 0.110 |
Why?
|
| Age Distribution | 1 | 2012 | 204 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2014 | 677 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 530 | 0.100 |
Why?
|
| Gene Expression | 1 | 2016 | 1284 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2014 | 1990 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1673 | 0.100 |
Why?
|
| Reproducibility of Results | 7 | 2013 | 2705 | 0.100 |
Why?
|
| Discriminant Analysis | 2 | 2010 | 66 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 756 | 0.100 |
Why?
|
| Alleles | 1 | 2014 | 1127 | 0.090 |
Why?
|
| Genotype | 1 | 2014 | 1850 | 0.090 |
Why?
|
| Incidence | 1 | 2012 | 1576 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1464 | 0.080 |
Why?
|
| Fractals | 1 | 2007 | 42 | 0.080 |
Why?
|
| Radiology | 1 | 2008 | 194 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2356 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 99 | 0.060 |
Why?
|
| Bone Density | 1 | 2004 | 209 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2004 | 121 | 0.050 |
Why?
|
| Risk | 1 | 2004 | 674 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 159 | 0.050 |
Why?
|
| Biopsy | 2 | 2017 | 1161 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 5416 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 29 | 0.050 |
Why?
|
| Automation | 2 | 2014 | 106 | 0.050 |
Why?
|
| Benzoates | 1 | 2001 | 44 | 0.050 |
Why?
|
| Pollen | 1 | 2001 | 80 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 5974 | 0.050 |
Why?
|
| Fuzzy Logic | 2 | 2010 | 15 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2001 | 363 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2010 | 369 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 90 | 0.040 |
Why?
|
| Water | 2 | 2014 | 275 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2017 | 52 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 96 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 3674 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1204 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 392 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2008 | 574 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1565 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 71 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 552 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2600 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 813 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 365 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 355 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1683 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 269 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 220 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1135 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 534 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1937 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 364 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2011 | 357 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 261 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 73 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 406 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 602 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4210 | 0.020 |
Why?
|
| Calcaneus | 1 | 2004 | 34 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 579 | 0.010 |
Why?
|
| Mass Screening | 1 | 2007 | 617 | 0.010 |
Why?
|
| Mineral Oil | 1 | 2001 | 1 | 0.010 |
Why?
|
| Papaver | 1 | 2001 | 2 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2001 | 10 | 0.010 |
Why?
|
| Zea mays | 1 | 2001 | 23 | 0.010 |
Why?
|
| Viscosity | 1 | 2001 | 46 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 42 | 0.010 |
Why?
|
| Seeds | 1 | 2001 | 49 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 101 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 268 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 202 | 0.010 |
Why?
|